Boston University Charles River Campus
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Boston University Charles River Campus sits in the top decile of US sponsors by registered trial count (#234 of 15,742 sponsors by registered trial count).
Boston University Charles River Campus: 104 sponsored US clinical trials, 23 recruiting.
Boston University Charles River Campus sponsors 104 registered US clinical trials on ClinicalTrials.gov, 23 of them currently recruiting, and 72 completed. 2 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Anxiety Disorders, with 3 trials.
Top-decile sponsor footprint
Boston University Charles River Campus ranks in the top decile of sponsors by registered trial count (#234 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
72 of 76 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (94.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
104 total, page 2 of 3
Flourishing and Virtue in Cognitive-Behavioral Therapy for Anxiety and Depressive Disorders
NCT05120232
Effects of an Overground Propulsion Neuroprosthesis in Community-dwelling Individuals After Stroke
NCT06459401
Internet-based Video-conferencing to Address Alcohol Use and Pain: a Pilot Trial
NCT04441593
Wearable Sensors in Knee OA
NCT04243096
Improving Working Memory in Older Adults
NCT04362696
Neural and Behavioral Effects of Cognitive Bias Modification (CBM)
NCT04430543
Telehealth Psychotherapy for Depression in Parkinson's Disease
NCT03993041
Engaging Working Memory and Distress Tolerance to Aid Smoking Cessation
NCT03565497
Internet-based Videoconferencing to Address Alcohol Use and Pain
NCT03982433
Walking and mHealth to Increase Participation in Parkinson Disease
NCT03517371
Motivation and Skills Support (MASS)
NCT03404219
MI With Text Messaging to Reduce Sexual Risk and Hazardous Drinking Among MSM
NCT03755661
Transdiagnostic CBT for Comorbid Alcohol Use and Anxiety Disorders
NCT03230006
Alcohol and Sex Risk Intervention for MSM Supplement
NCT03522948
Isolating Mechanisms in the Treatment of Borderline Personality Disorder
NCT03408860
Interdisciplinary Study of A Novel Anticonvulsant in Alcoholism
NCT02901041
Bridging Community Gaps Photovoice
NCT03291717
Evidence-Based Interventions to Enhance Outcomes Among Struggling Readers
NCT04059939
"Recovery 4 US" - A Photovoice-based Social Media Program
NCT03266614
Perception, Cognition, and Gait in Parkinson's Disease
NCT03241966
Assessment of the Predictors and Moderators of Health Behavior Change
NCT03139656
Engaging Siblings of Adults With Autism in Future Planning
NCT03374072
Comparing Thinking Skills for Work (TSW)Home Practice Program With Traditional TSW Program
NCT03005574
Cognitive and Emotional Skills to Aid Smoking Prevention
NCT03058991
Testing Psychosocial Treatment Planning Methods for Youth Anxiety and Depression
NCT03610373
AWARE Intervention: Feasibility and Efficacy Trial at Three University Health Services Centers
NCT03961633
Vocational Empowerment Photovoice (VEP)
NCT02784938
Enhancing Therapy Process With Movement Strategies
NCT03140124
Testing the Efficacy of Opening Doors: A Career Guidance Intervention for Individuals With Psychiatric Disabilities
NCT03409991
Exercise and Cognitive Training
NCT02326389
Testing Effectiveness of a Peer-Led Intervention to Enhance Community Integration
NCT02508480
Brain Mechanisms for Language Processing in Adolescents With Autism Spectrum Disorder
NCT02700074
Investigating Phenotypic Profiles of Children and Adolescents With ASD
NCT02700113
Improving Therapeutic Learning in Depression: Proof of Concept
NCT02376257
Efficacy of Adjunctive Exercise for the Behavioral Treatment of Major Depression
NCT02176408
Treatment Study for Non-Suicidal Self-Injury
NCT02060448
Mobile Health Technology to Promote Physical Activity in Persons With Parkinson Disease
NCT01955889
A Pilot Study of Positive Affect Training
NCT01853098
Understanding How Cognitive Remediation Works
NCT01683539
A Multifactorial Exercise Program to Reduce Falls in People With Parkinson Disease
NCT02302144
Computerized Cognitive-Behavioral Therapy for Auditory Hallucinations
NCT02192593
Assessing the Effects of a Neurobehavioral Intervention on Symptoms of Obsessive Compulsive Disorder
NCT01414023
Can Computer-based Telephone Counseling Improve Long-term Adherence to Strength Training in Elders With Knee OA?
NCT01394874
Efficacy Evaluation of a Unified Transdiagnostic Treatment for Anxiety Disorders
NCT01243606
Integration of Continuous Glucose Monitoring Into a BiHormonal Closed-Loop Artificial Pancreas
NCT01161862
Systems of Support Study for Childhood Depression
NCT01159041
Closed-loop Glucose Control for Automated Management of Type 1 Diabetes
NCT00811317
Exposure, D-Cycloserine Enhancement, and Genetic Modulators in Panic Disorder
NCT00790868
Effect of D-cycloserine Plus Cognitive Behavioral Therapy on People With Social Phobia
NCT00515879
Efficacy of D-Cycloserine for Enhancing the Effects of CBT for Substance Use
NCT00430573
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 3 |
| Phase 3 | 2 |
Therapeutic Areas
What is open in the Boston University Charles River Campus pipeline
23 recruiting of 104 indexed (22% open); 72 completed (69%).
Phase mix: 2 late (III/IV) vs 5 early (I/II) (early-phase heavy).
Top condition: Anxiety Disorders (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Boston University Charles River Campus: open-pipeline peers nationwide
Peers matched on 104 registered trials and 22% open enrollment, not the therapeutic-area sidebar.
Boston University Charles River Campus sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 104 trials (± recruiting share)
- Kessler Foundation · 104 trials · 33% recruiting
- Virginia Polytechnic Institute and State University · 104 trials · 17% recruiting
- Butler Hospital · 103 trials · 9% recruiting
- Augusta University · 106 trials · 12% recruiting
Sponsors near 22% open enrollment (± trial volume)
- Vanda Pharmaceuticals · 22% recruiting · 68 trials
- ALX Oncology · 22% recruiting · 9 trials
- Biosense Webster · 22% recruiting · 18 trials
- Englewood Hospital and Medical Center · 22% recruiting · 18 trials
Related
What to do with this Boston University Charles River Campus page
104 registered trials is a research-attention snapshot, not an endorsement of Boston University Charles River Campus or any single study.
- 23 of Boston University Charles River Campus's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Anxiety Disorders is the condition Boston University Charles River Campus studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Anxiety Disorders trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Boston University Charles River Campus pipeline card: 104 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.